Cited by 833D Printing in Biomedical ResearchTissue Engineering and Regenerative MedicineHydrogels: synthesis, properties, applications

Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system

Open access
Ma, Liang, Barker, Jeremy, Zhou, Changchun, Li, Wei, Zhang, Jing, Lin, Biaoyang, Foltz, Gregory, Küblbeck, Jenni +1 more·2012·Biomaterials

Abstract

A three-dimensional micro-scale perfusion-based two-chamber (3D-μPTC) tissue model system was developed to test the cytotoxicity of anticancer drugs in conjunction with liver metabolism. Liver cells with different cytochrome P450 (CYP) subtypes and glioblastoma multiforme (GBM) brain cancer cells were cultured in two separate chambers connected in tandem. Both chambers contained a 3D tissue engineering scaffold fabricated with biodegradable poly(lactic acid) (PLA) using a solvent-free approach. We used this model system to test the cytotoxicity of anticancer drugs, including temozolomide (TMZ) and ifosfamide (IFO). With the liver cells, TMZ showed a much lower toxicity to GBM cells under both 2D and 3D cell culture conditions. Comparing 2D, GBM cells cultured in 3D had much high viability under TMZ treatment. IFO was used to test the CYP-related metabolic effects. Cells with different expression levels of CYP3A4 differed dramatically in their ability to activate IFO, which led to strong metabolism-dependent cytotoxicity to GBM cells. These results demonstrate that our 3D-μPTC system could provide a more physiologically realistic in vitro environment than the current 2D monolayers for testing metabolism-dependent toxicity of anticancer drugs. It could therefore be used as an important platform for better prediction of drug dosing and schedule towards personalized medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2012.02.054

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ma et al. established a two-chamber (3D-mPTC) tissue model based on three-dimensional microscale perfusion, combined with cytotoxicity of liver metabolism anticancer drugs for detection.

    “Ma et al. established a two-chamber (3D-mPTC) tissue model based on three-dimensional microscale perfusion in early research, which was combined with the cytotoxicity of liver metabolism anticancer drugs for detection, and realized the most basic organ chip model (Fig. 7b)219.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ma, L., Barker, J., Zhou, C., Li, W., Zhang, J., Lin, B., Foltz, G., Küblbeck, J., & Honkakoski, P.
Affiliations
  • University of Washington (US)
  • The University of Texas at Austin (US)
  • Swedish Medical Center (US)
  • University of Eastern Finland (FI)
Corresponding author
  • Li, Wei
  • Lin, Biaoyang
Venue
Biomaterials
Publisher
Elsevier BV
Published
2012-06
Volume
33
Issue
17
Pages
4353-4361
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2064252921
Cited by
83
References
69
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 8 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 8 · 2017: 6 · 2016: 9 · 2015: 6 · 2014: 7 · 2013: 4 · 2012: 1
FWCI
3.28
Type
journal article
Language
en
Open access
Locations
  • Biomaterials (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH (R21EB008573)
  • NSF (CMMI-0348767, CMMI-1131710)
  • University of Eastern Finland
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
Keywords
personalized medicine, anticancer drug cytotoxicity, drug metabolism, cytochrome P450, CYP3A4, glioblastoma, temozolomide, ifosfamide, 3D cell culture, polylactic acid scaffolds, drug toxicity prediction
MeSH terms
Temozolomide, Cell Survival, Dacarbazine, Glioblastoma, Humans, Ifosfamide, Liver, Microscopy, Electron, Scanning, Perfusion, Polyesters, Diffusion Chambers, Culture, Porosity, Cell Culture Techniques, Tissue Engineering, Cell Line, Tumor, Cytochrome P-450 CYP3A, Tissue Scaffolds, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review